RPRX

Royalty Pharma
D

RPRX

Arincen67/100B

Royalty Pharma dividend

Yes. Royalty Pharma pays 0.24 USD a share every quarter: 0.94 USD a year at the current rate, a dividend yield of 1.40% at today's price of 67.29.

Annual dividend
0.94 USD
Dividend yield (indicated)
1.40%
Payout ratio
68.62%
Years of dividend growth
6
Frequency
Quarterly
Last payment
0.24 USD
Last ex-dividend date
13 Nov 2026
Last payment date
10 Dec 2026
Next ex-dividend date
13 Nov 2026
Dividend growth, 5 years (a year)
24.0%
First dividend
14 Sept 2020

Dividends by year

Dividends per share
Ex-dividend dateDividendRecord datePay dateDeclared
13 Nov 20260.24 USD 13 Nov 202610 Dec 202616 Oct 2026
14 Aug 20260.24 USD 14 Aug 202610 Sept 202617 Jul 2026
15 May 20260.24 USD 15 May 202610 Jun 202617 Apr 2026
20 Feb 20260.24 USD 20 Feb 202610 Mar 20269 Jan 2026
14 Nov 20250.22 USD 14 Nov 202510 Dec 202517 Oct 2025
15 Aug 20250.22 USD 15 Aug 202510 Sept 202518 Jul 2025
16 May 20250.22 USD 16 May 202510 Jun 202521 Apr 2025
21 Feb 20250.22 USD 21 Feb 202510 Mar 20259 Jan 2025
15 Nov 20240.21 USD 15 Nov 202410 Dec 202411 Oct 2024
16 Aug 20240.21 USD 16 Aug 202413 Sept 202417 Jul 2024
16 May 20240.21 USD 17 May 202414 Jun 202417 Apr 2024
15 Feb 20240.21 USD 16 Feb 202415 Mar 202419 Jan 2024
16 Nov 20230.20 USD 17 Nov 202315 Dec 202316 Oct 2023
17 Aug 20230.20 USD 18 Aug 202315 Sept 202317 Jul 2023
18 May 20230.20 USD 19 May 202315 Jun 202317 Apr 2023
15 Feb 20230.20 USD 16 Feb 202315 Mar 20239 Jan 2023
17 Nov 20220.19 USD 18 Nov 202215 Dec 202217 Oct 2022
18 Aug 20220.19 USD 19 Aug 202215 Sept 202215 Jul 2022
19 May 20220.19 USD 20 May 202215 Jun 202218 Apr 2022
17 Feb 20220.19 USD 18 Feb 202215 Mar 20226 Jan 2022
18 Nov 20210.17 USD 19 Nov 202115 Dec 202115 Oct 2021
19 Aug 20210.17 USD 20 Aug 202115 Sept 202116 Jul 2021
19 May 20210.17 USD 20 May 202115 Jun 202115 Apr 2021
18 Feb 20210.17 USD 19 Feb 202115 Mar 20218 Jan 2021
19 Nov 20200.15 USD 20 Nov 202015 Dec 202015 Oct 2020
14 Sept 20200.15 USD 15 Sept 202030 Sept 20202 Sept 2020

Each calendar year's dividends by payment date, per share and adjusted for stock splits, against the year before.

Is the dividend covered?

EPS Free cash flow a share Dividends paid a share

Each fiscal year's diluted EPS and free cash flow a share against the dividends paid a share (the cash flow statement's dividends over the diluted share count). When they are well above the dividend, it is paid with room to spare.

Is the dividend yield high or low for this stock?

WarningThe dividend yield of 1.40% is close to its 5-year low of 1.39% (high 3.46%, median 2.32%): the dividend buys less income for the price than at almost any time in five years.

Median 2.32%
Today 1.40%
1.39%
3.46%

The yearly dividend (the latest times the payments a year) over each day's close, five years. A yield near its low usually means the price has risen faster than the dividend.

See also:Dividend yield,Stock buybacks,Financials

Common questions about Royalty Pharma's dividend

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.